These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30287267)

  • 1. Exosomes as adjuvants for the recombinant hepatitis B antigen: First report.
    Jesus S; Soares E; Cruz MT; Borges O
    Eur J Pharm Biopharm; 2018 Dec; 133():1-11. PubMed ID: 30287267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen.
    Jesus S; Soares E; Borchard G; Borges O
    Nanomedicine (Lond); 2017 Oct; 12(19):2335-2348. PubMed ID: 28868964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
    Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
    Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production.
    Jesus S; Soares E; Borchard G; Borges O
    Mol Pharm; 2018 Jan; 15(1):72-82. PubMed ID: 29160080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.
    Soares E; Groothuismink ZMA; Boonstra A; Borges O
    Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Xie Y; Sun HX; Li D
    Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H; Han Q; Zhao H; Xu D; Zhang J
    Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.
    Jesus S; Soares E; Costa J; Borchard G; Borges O
    Int J Pharm; 2016 May; 504(1-2):59-69. PubMed ID: 26976502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
    J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles.
    Lebre F; Pedroso de Lima MC; Lavelle EC; Borges O
    Int J Pharm; 2018 Dec; 552(1-2):7-15. PubMed ID: 30244149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
    Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S
    Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen.
    Soares E; Jesus S; Borges O
    Eur J Pharm Biopharm; 2018 Oct; 131():33-43. PubMed ID: 30048745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine.
    Liu X; Min Q; Song H; Yue A; Li Q; Zhou Q; Han W
    J Nanobiotechnology; 2023 Nov; 21(1):441. PubMed ID: 37993870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
    Grenfell RF; Shollenberger LM; Samli EF; Harn DA
    Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
    Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
    J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
    Dong SF; Chen JM; Zhang W; Sun SH; Wang J; Gu JX; Boraschi D; Qu D
    Int Immunopharmacol; 2007 Jun; 7(6):725-33. PubMed ID: 17466906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.